Indeed, continuous subcutaneous infusion of GLP-1 or extendin-4 (a naturally occurring analogue of GLP-1) for 3 days in both insulin-resistant and type 2 diabetic rat models normalized their impaired trabecular architecture and promoted bone formation via an insulin-independent mechanism [12, 13]. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.